States / Washington / SB 5921

SB 5921 Reported from Committee

Concerning psilocybin.

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Bill — · 7.7K words Open full page ↗

 S-3555.1

SENATE BILL 5921

State of Washington

69th Legislature

2026 Regular Session

By Senators Salomon, Lovelett, Nobles, Riccelli, Saldaña, Shewmake, and Slatter

Prefiled 12/19/25. Read first time 01/12/26. Referred to Committee on Health & Long-Term Care.

AN ACT Relating to psilocybin; amending RCW 69.50.101 and 69.50.101 ; adding a new chapter to Title 43 RCW; providing effective dates; and providing an expiration date.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:

NEW SECTION. Sec. 1. The legislature recognizes the need for clinical treatment for serious and otherwise treatment-resistant conditions. The legislature recognizes that scientific evidence has found that psilocybin can provide medically significant relief for diagnosed conditions. The legislature recognizes the importance of clear training standards, oversight mechanisms, and protections for clinicians and patients. The legislature therefore resolves to create the Washington medical use of psilocybin program under the supervision of the department of health to provide safe access to needed medical treatment services.

NEW SECTION. Sec. 2. This act may be known and cited as the Washington medical psilocybin act.

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.